{"url_path":"/sec/apyx/8-k/2026-06-17/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/719135/0001493152-26-029081-index.html","accession_number":"0001493152-26-029081","cik":"0000719135","ticker":"APYX","issuer_name":"Apyx Medical Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/719135/0001493152-26-029081-index.html","primary_entity_key":"0000719135","primary_entity_name":"Apyx Medical Corp"},"word_count":87,"has_tables":true,"body_markdown":"**Item\n9.01.**\n**Financial\nStatements and Exhibits.**\n\n \n\n(d)\nExhibits\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n10.1\n \n[Letter Agreement between Company and Stavros Vizirgianakis, dated June 11, 2026.](ex10-1.htm)\n\n104\n \nCover\nPage Interactive Data File embedded within the Inline XBRL document\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**APYX\nMEDICAL CORPORATION**\n\n \n \n \n\nDate:\nJune 17, 2026\nBy:\n\n*/s/\nMatthew Hill*\n\n \nName:\n\nMatthew\nHill\n\n \nTitle:\nChief\nFinancial Officer, Secretary and Treasurer"}